Cancer Biology and Medicine · 2020 · 25 citations · 23 references
MedicineMolecular MedicineOncologyCancer ScreeningMolecular DiagnosticsMolecular OncologyBiomarker ValidationCancer BiomarkersCancer Molecular DiagnosticsMicrorna BiologyNoncoding Rna BiologyNoncoding Rna In CancerDiagnostic BiomarkersLung DiseasesMann - Whitney U TestNon-coding Rna BiomarkersNoncoding Rna Biomarker DiscoveryQuantitative Polymerase Chain ReactionReal-time Polymerase Chain Reaction (Pcr)Receiver Operating Characteristic Analysis
: MiR-339-3p was significantly upregulated in patients with NSCLC compared with participants without cancer, suggesting a diagnostic prediction value for high-risk individuals. Therefore, miR-339-3p expression could be a potential blood-based biomarker for NSCLC.
23